Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value (2014 - 2025)

Corbus Pharmaceuticals Holdings has reported Enterprise Value for 12 years, with the latest figure at -$61.2 million in Q4 2025.

• On a quarterly basis, Enterprise Value fell 1045.85% year-over-year to -$61.2 million in Q4 2025; TTM through Dec 2025 was -$61.2 million, a 1045.85% decrease from a year earlier, with the FY2025 full-year figure at -$64.1 million, down 1099.98% from the prior year.
• Enterprise Value was -$61.2 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $54.6 million in the prior quarter.
• The five-year high for Enterprise Value was $7.3 billion in Q1 2021, with the low at -$67.8 million in Q1 2025.
• Average Enterprise Value over 5 years is $1.2 billion, with a median of $73.2 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 19834.5% in 2024, then slumped 1045.85% in 2025.
• Over 5 years, Enterprise Value stood at $2.2 billion in 2021, then tumbled by 102.05% to -$45.4 million in 2022, then soared by 112.81% to $5.8 million in 2023, then plunged by 191.93% to -$5.3 million in 2024, then plunged by 1045.85% to -$61.2 million in 2025.
• The last three Enterprise Value figures came in at -$61.2 million (Q4 2025), $54.6 million (Q3 2025), and -$32.0 million (Q2 2025), per Business Quant data.